A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease

American Journal of Geriatric Psychiatry

Volumn 13, Issue 12, 2005, Pages 1062-1066

  Uchida, Naohiko ^a,b   Ujike, Hiroshi ^a   Tanaka, Yuji ^a   Sakai, Ayumu ^a,c   Yamamoto, Mitsutoshi ^d   Fujisawa, Yoshikatsu ^e   Kanzaki, Akihiro ^f   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Seiwakai Nishikawa Hospital   (Japan)

^c Kasaoka Hospital   (Japan)

^d KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^e Kinoko Espoir Hospital   (Japan)

^f HIROSHIMA CITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; SIGMA OPIATE RECEPTOR; MESSENGER RNA;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; DOWN REGULATION; EXON; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE;

AGED; ALLELES; ALZHEIMER DISEASE; DOWN-REGULATION; EXONS; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, SIGMA; RNA, MESSENGER;

EID: 33645739693     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/00019442-200512000-00005     Document Type: Article

References (28)

1. Daly MJ: Untangling the genetics of a complex disease. JAMA 1998; 280:652-653
2. Lendon CL, Ashall F, Goats AM: Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 1997; 277:825-831
3. Martin WR, Eades CE, Thompson JA, et al: The effects of morphine- and nalorphin- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976; 197:517-532
4. Walker JM, Bowen WD, Walker FO, et al: Sigma receptors: biology and function. Pharmacol Rev 1997; 42:355-402
5. Quirion R, Bowen WD, Itzhak Y, et al: A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 1992; 13:85-86
6. Matsuno K, Matsunaga K, Senda T, et al: Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. J Pharmacol Exp Ther 1993; 265:851-859
7. Monnet FP, Debonnel G, Junien JL, et al: N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol 1990; 179:441-445
8. Maurice T, Su TP, Parish DW, et al: PRE-084, a sigma-selective PCP derivative, attenuates MK-801-induced impairment of learning in mice. Pharmacol Biochem Behav 1994; 49:859-869
9. 1 receptor-agonist properties, facilitates NMDA receptor-dependent learning in mice. Eur J Pharmacol 1997; 328:9-18
10. 1 receptor-agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur J Pharmacol 1996; 315:1-10
11. Zou LB, Yamada K, Nabeshima T: Sigma receptor ligands (+)-SKF10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats. Eur J Pharmacol 1998; 355:1-10
12. 1 receptor agonist PRE-084 against spatial-learning deficits in aged rats. Eur J Pharmacol 2001; 431:223-227
13. 1) receptor-agonists confirmed by in-vivo antisense strategy in the mouse. Brain Res 2001; 898:113-121
14. 1 receptors: implications for antidepressants. J Pharmacol Exp Ther 2002; 303:1227-1237
15. Yamada M, Ikeuchi T, Hatanaka H: The neurotrophic action and signaling of epidermal growth factor. Prog Neurobiol 1997; 51:19-37
16. 1 receptors potentiate epidermal growth factor signaling toward neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution. Synapse 2004; 53:90-103
17. Kekuda R, Prasad PD, Fei YJ, et al: Cloning and functional expression of the human Type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 1996; 229:553-558
18. Ishiguro H, Ohtsuki T, Toru M, et al: Association between polymorphisms in the Type 1 sigma-receptor gene and schizophrenia. Neurosci Lett 1998; 257:45-48
19. 1 receptor gene associated with alcoholism. Biol Psychiatry 2004; 55:85-90
20. Uchida N, Ujike H, Kuroda S, et al: No association between the sigma receptor Type 1 gene and schizophrenia: results of analysis and meta-analysis of case-control studies. BMC Psychiatry 2003; 3:13
21. Wenham PR, Price WH, Blandell G: Apolipoprotein-E genotyping by one-stage PCR. Lancet 1991; 337:1158-1159
22. 2+ concentration. J Pharmacol Exp Ther 2000; 293:788-798
23. 1 receptors. Proc Natl Acad Sci U S A 2001; 98:491-496
24. Coder EH, Saunders AM, Strittmatter WJ, et al: Gene dose of apolipoprotein-E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993; 261:921-923
25. Masliah E, Mallory M, Ge N, et al: Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol 1995; 136:107-122
26. Lomnitski L, Oron L, Sklan D, et al: Distinct alterations in phospholipid metabolism in brains of apolipoprotein-E-deficient mice. J Neurosci Res 1999; 58:586-592
27. 1 binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther 2003; 306:718-725
28. 1-binding site. Proc Natl Acad Sci U S A 1996; 93:8072-8077